A concomitant case of pathologically proven IgG4-related disease and ANCA-associated vasculitis: case report

References

• Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732–738.
   PubMed Web of Science ®Google Scholar
• Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366:539–551.
   PubMed Web of Science ®Google Scholar
• Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22:21–30.
   PubMed Web of Science ®Google Scholar
• Houghton DC, Troxell ML. An abundance of IgG4+ plasma cells is not specific for IgG4-related tubulointerstitial nephritis. Mod Pathol. 2011;24:1480–1487.
   PubMed Web of Science ®Google Scholar
• Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25:1181–1192.
   PubMed Web of Science ®Google Scholar
• Chang SY, Keogh KA, Lewis JE, et al. IgG4-positive plasma cells in granulomatosis with polyangiitis (Wegener’s): a clinicopathologic and immunohistochemical study on 43 granulomatosis with polyangiitis and 20 control cases. Hum Pathol. 2013;44:2432–2437.
   PubMed Web of Science ®Google Scholar
• Mukhtyar C, Guillevin L, Cid MC, et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis. 2009;68:310–317.
   PubMed Web of Science ®Google Scholar
• Perugino CA, Stone JH. Treatment of IgG4-related disease: current and future approaches. Z Rheumatol. 2016;75:681–686.
   Web of Science ®Google Scholar
• Khosroshahi A, Wallace ZS, Crowe JL, et al. International consensus guidance statement on the management and treatment of IgG4-Related disease. Arthritis Rheumatol. 2015;67:1688–1699.
   PubMed Web of Science ®Google Scholar
• Kiyama K, Yoshifuji H, Kandou T, et al. Screening for IgG4-type anti-nuclear antibodies in IgG4-related disease. BMC Musculoskelet Disord. 2015;16:129.
   PubMed Web of Science ®Google Scholar
• Watts R, Lane S, Hanslik T, et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis. 2007;66:222–227.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Takahashi H, Suzuki C, et al. Analysis of serum IgG subclasses in Churg-Strauss syndrome – the meaning of elevated serum levels of IgG4. Intern Med. 2010;49:1365–1370.
   PubMed Web of Science ®Google Scholar
• Kotani S, Wakamatsu R, Itoh A, et al. Proteinase 3 anti-neutrophil cytoplasmic antibody (PR3-ANCA) positive IgG4-related retroperitoneal fibrosis: utility of PET-CT with 18F-fluorodeoxy glucose (FDG). Intern Med. 2012;51:755–758.
   Web of Science ®Google Scholar
• Iwanami M, Ogawa T, Tanaka Y, et al. [Orbital apex syndrome due to relapse during steroid tapering in a patient with MPO-ANCA-positive IgG4-related hypertrophic pachymeningitis]. Rinsho Shinkeigaku. 2014;54:52–55.
   Google Scholar
• Popkirov S, Kowalski T, Schlegel U, et al. Immunoglobulin-G4-related hypertrophic pachymeningitis with antineutrophil cytoplasmatic antibodies effectively treated with rituximab. J Clin Neurosci. 2015;22:1038–1040.
   Web of Science ®Google Scholar
• Ohno K, Matsuda Y, Arai T, et al. Myeloperoxidase-antineutrophil cytoplasmic antibody-positive otitis media and rhinosinusitis with pathological features of immunoglobulin g4-related disease: a case report. Ann Otol Rhinol Laryngol. 2016;125:516–521.
   Web of Science ®Google Scholar
• Hanioka Y, Yamagami K, Yoshioka K, et al. Churg-Strauss syndrome concomitant with chronic symmetrical dacryoadenitis suggesting Mikulicz’s disease. Intern Med. 2012;51:2457–2461.
   Web of Science ®Google Scholar
• Alexandraki KI, Kaltsatou M, Chatzellis E, et al. Hypophysitis in IgG4-related disease associated with p-ANCA vasculitis. Am J Med. 2016;129:e25–e27.
   Web of Science ®Google Scholar
• Tosovský M, Bradna P, Laco J, et al. Case 1-2012: ANCA associated glomerulonephritis in combination with IgG4-positive mediastinal mass in a patient with ankylosing spondylitis treated with TNF alpha inhibitors. Acta Medica (Hradec Kralove). 2012;55:42–46.
   Google Scholar
• Della-Torre E, Lanzillotta M, Campochiaro C, et al. Antineutrophil cytoplasmic antibody positivity in IgG4-related disease: a case report and review of the literature. Medicine (Baltimore). 2016;95:e4633.
   PubMed Web of Science ®Google Scholar
• Danlos F-X, Rossi GM, Blockmans D, et al. Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: a new overlap syndrome. Autoimmun Rev. 2017;16:1036–1043.
   PubMed Web of Science ®Google Scholar
• Millet A, Martin KR, Bonnefoy F, et al. Proteinase 3 on apoptotic cells disrupts immune silencing in autoimmune vasculitis. J Clin Invest. 2015;125:4107–4121.
   Web of Science ®Google Scholar
• Grados A, Ebbo M, Piperoglou C, et al. T cell polarization toward TH2/TFH2 and TH17/TFH17 in patients with IgG4-related disease. Front Immunol. 2017;8:2–11.
   Web of Science ®Google Scholar
• Yates M, Watts RA, Bajema IM, et al. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis. 2016;75:1583–1594.
   PubMed Web of Science ®Google Scholar
• Carruthers MN, Topazian MD, Khosroshahi A, et al. Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis. 2015;74:1171–1177.
   PubMed Web of Science ®Google Scholar
• Ebbo M, Grados A, Samson M, et al. Long-term efficacy and safety of rituximab in IgG4-related disease: data from a French nationwide study of thirty-three patients. Weber MS, editor. PLoS One. 2017;12:e0183844.
   PubMed Web of Science ®Google Scholar
• Kallenberg CG, Pathogenesis and treatment of ANCA-associated vasculitides. Clin Exp Rheumatol. 2015;33(4 Suppl 92);S11-4.
   PubMed Web of Science ®Google Scholar
• Mattoo H, Mahajan VS, Della-Torre E, et al. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. J Allergy Clin Immunol. 2014;134:679–687.
   PubMed Web of Science ®Google Scholar